Novo Nordisk A/S ADR buy Sanford C. Bernstein
Start price
09.09.25
/
50%
€45.85
Target price
09.09.26
-
Performance (%)
-11.23%
Price
17.12.25
€40.70
Summary
This prediction is currently active. The price of Novo Nordisk A/S ADR has decreased since the start of the prediction. Compared to the start price this results in a performance of -11.23%. This prediction currently runs until 09.09.26. The prediction end date can be changed by Sanford_C__Bernstein at any time. Sanford_C__Bernstein has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novo Nordisk A/S ADR | -3.095% | -3.095% |
| iShares Core DAX® | -1.212% | 1.925% |
| iShares Nasdaq 100 | -4.714% | -1.810% |
| iShares Nikkei 225® | -2.976% | -2.660% |
| iShares S&P 500 | -2.744% | -0.448% |
Comments by Sanford_C__Bernstein for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE:NVO) was upgraded by analysts at Sanford C. Bernstein from a "market perform" rating to an "outperform" rating.
Ratings data for NVO provided by MarketBeat